Telomere mean length in patients with diabetic retinopathy

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Sharma, Rupali ^a   Gupta, Amod ^a   Thungapathra, M ^a   Bansal, Reema ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; DIABETIC RETINOPATHY; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; TELOMERE; TELOMERE HOMEOSTASIS;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; TELOMERE; TELOMERE HOMEOSTASIS;

EID: 84950287883     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep18368     Document Type: Article

References (34)

1. Aviv, A. & Aviv, H. Reflections on telomeres, growth, aging, and essential hypertension. Hypertension 29, 1067-1072 (1997).
2. Von Zglinicki, T., Pilger, R. & Sitte, N. Accumulation of single-strand breaks is the major cause of telomere shortening in human fibroblasts. Free Radic Biol Med. 28, 64-74 (2000).
3. Harley, C. B. Telomere loss: mitotic clock or genetic time bomb ? Mutat Res. 256, 271-282 (1991).
4. Saretzki, G. & Von Zglinicki, T. Replicative aging, telomeres, and oxidative stress. Ann N Y AcadSci. 959, 24-29 (2002).
5. Collins, K. & Mitchell, J. R. Telomerase in the human organism. Oncogene. 21, 564-79 (2002).
6. Olivieri, F. et al. Leukocyte telomere shortening in elderly Type 2 DM patients with previous myocardial infarction. Atherosclerosis. 206, 588-93 (2009).
7. Fitzpatrick, A. L. et al. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol. 165, 14-21 (2007).
8. Uziel, O. et al. Telomere dynamics in arteries and mononuclear cells of diabetic patients: effect of diabetes and of glycemic control. Exp Gerontol 42, 971-978 (2007).
9. Jeanclos, E. et al. Shortened telomere length in white blood cells of patients with IDDM. Diabetes. 47, 482-486 (1998).
10. Sampson, M. J., Winterbone, M. S., Hughes, J. C., Dozio, N. & Hughes, D. A. Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. Diabetes Care. 29, 283-289 (2006).
11. Epel, E. S. et al. Cell aging in relation to stress arousal and cardiovascular disease risk factors. Psychoneuroendocrinology. 31, 277-287 (2006).
12. Weili, Z. et al. Functional Haplotypes of the hTERT Gene, Leukocyte Telomere Length Shortening, and the Risk of Peripheral Arterial Disease. PLOS One. 10, e47029 (2012).
13. Perez-Rivera, J. A., Pabon-Osuna, P., Cieza-Borrella, C., Martin-Herrero, F. & Gonzalez-Porras, J. R. Prognostic value of telomere length in acute coronary syndrome. Mech Ageing Dev. 133, 695-697 (2012).
14. Fong, D. S., Aiello, L. P. & Klein, R. Diabetic Retinopathy. Diabetes care. 27, 2540-2553 (2004).
15. Chiu, C.-P. & Harley, C. B. Replicative senescence and cell immortality: the role of telomeres and telomerase. Proc Soc Exp Biol Med. 214, 99-106 (1997).
16. Axelrod, N. Of telomeres and tumors. Nature Med. 2, 158-159 (1996).
17. Dudinskaya, E. N. et al. Short telomere length is associated with arterial aging in patients with type 2 diabetes mellitus. Endocr Connect. 4, 136-43 (2015).
18. Gardner, J. P. et al. Rise in insulin resistance is associated with escalated telomere attrition. Circulation. 111, 2171-2177 (2005).
19. Allsopp, R. C.,Vaziri, H., Patterson, C., Goldstein, S. & Younglai, E. V. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 89, 10114-10118 (1992).
20. Harley, C. B., Futcher, A. B. & Greider, C. W. Telomeres shorten during ageing of human fibroblasts. Nature (London) 345, 458-460 (1990).
21. Slagboom, P. E., Droog, S. & Boomsma, D. I. Genetic determination of telomere size in humans: a twin study of three age groups. Am J Hum Genet. 55, 876-882 (1994).
22. Vaziri, H. et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet. 52, 661-667 (1993).
23. Aviv, A. & Aviv, H. Telomeres and essential hypertension. Am J Hypertens. 12, 427-32 (1999).
24. Samani, N. J. et al. Telomere shortening in atherosclerosis. Lancet. 358, 472-3 (2001).
25. Okuda, K. et al. Telomere attrition of the human abdominal aorta: relationships with age and athero- sclerosis. Atherosclerosis. 152, 391-8 (2000).
26. Benetos, A. et al. Short telomeres are associated with increased carotid atherosclerosis in hypertensive subjects. Hypertension. 43, 182-5 (2004).
27. Cawthon, R. M. et al. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 361, 393-5 (2003).
28. Adaikalakoteswari, A., Balasubramanyam, M. & Mohan, V. Telomere shortening occurs in Asian Indian Type 2 diabetic patients. Diabet Med. 22, 1151-1156 (2005).
29. Tamura, Y. et al. β-cell telomere attrition in diabetes: inverse correlation between HbA1c and telomere length. J Clin Endocrinol Metab. 99, 2771-7 (2014).
30. Friedewald, W. T. et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem. 18, 499-502 (1972).
31. Sambrook, J. & Russel, D. W. Molecular Cloning. A Laboratory Manual, 3rd edn, Chapter 6 (2001).
32. Sambrook, J. & Russel, D. W. Molecular Cloning. A Laboratory Manual, 3rd edition, Chapter 8 (2001).
33. Guan, J. Z. et al. Change in the telomere length distribution with age in the Japanese population. Mol Cell Biochem. 304, 253-60 (2007).
34. Anand, A. et al. Does DcR1 (TNF-related apoptosis-inducing-ligand Receptor 3) have any role in human AMD pathogenesis? Scientific Reports. 4, 4114 (2014).